Kathryn Wortsman
Managing Partner @ Amplify Capital
Toronto, Canada
Kathryn Wortsman is a seed investor at Amplify Capital in Toronto focused on Health Care and Artificial Intelligence. Kathryn Wortsman - Managing Partner @ Amplify Capital
- Total investments:
- 11
- Last investment:
- Lead investor:
- 64%
Last updated:
For AI agents: llms.txt
Industries Kathryn Wortsman invests in
Stages Kathryn Wortsman invests in
Countries Kathryn Wortsman invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 4 (36%)
- Artificial Intelligence 3 (27%)
- Sales 2 (18%)
- Software 2 (18%)
- Education 2 (18%)
Stage
- Seed 4 (36%)
- Pre-Seed 3 (27%)
- Series A 3 (27%)
Country
- Canada 7 (64%)
- United States 1 (9%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Future Fields is committed to producing sustainable components for science through insect biotechnology. Its EntoEngine™ platform is the first to harness the genetic prowess of fruit flies to produce Earth’s most environmentally and economically sustainable biomolecules. Founded in 2018, Future Fields is headquartered in Edmonton, Canada andproudly backed by marquee venture capital firms and investors from Silicon Valley and beyond. Learn more about how Future Fields is enabling great science at https://futurefields.io/. | $8M / Series A / Jun 17, 2025 | ||
| EarlyBird is transforming lives through early detection of literacy challenges, including predicting risk for dyslexia | $3M / Seed / Nov 17, 2022 | ||
| LUCID curates and creates personalized therapeutic music using biometrics, psychometrics, and AI to improve mental health and wellness. | $2.3M / Seed / Aug 12, 2022 | ||
| LUCID curates and creates personalized therapeutic music using biometrics, psychometrics, and AI to improve mental health and wellness. | $2.5M / Pre-Seed / Aug 12, 2022 | ||
| Uvaro's career success platform includes training, paid experience, advancement and ongoing coaching to ensure long-term career success. Our training program includes on-demand and live classes, our virtual internships let companies hire talent based on performance, our coaching and mentorship network drive ongoing career growth. Our averagestudent lands their new role in less than 17 days from graduation at more than 2x their previous income, and in their new roles achieve 50% more sales than their peers. | $10.6M / Series A / Nov 03, 2021 | ||
| Uvaro's career success platform includes training, paid experience, advancement, and ongoing coaching to ensure long-term career success. Their training program includes on-demand and live classes. Their virtual internships let companies hire talent based on performance. Their coaching and mentorship network drive ongoing career growth. | $12M / Series A / Nov 03, 2021 | ||
| Pathway is a health tech company working on helping clinicians and patients access important medical information more effectively throughout the care journey. We leverage AI and big data to create a medical knowledge graph and software solutions that drive evidence-based medicine into clinical practice. | $1.3M / Seed / Oct 14, 2021 | ||
| Ditch Labs is a digital health company pioneering substance addiction treatment by combining AI-driven behavioural therapy with revolutionary drug delivery devices. Using a novel digital therapeutic approach, Ditch is aiming to solve the world’s leading cause of preventable death, starting with nicotine addiction. | $1.3M / Pre-Seed / May 01, 2021 | ||
| EarlyBird is transforming lives through early detection of literacy challenges, including predicting risk for dyslexia | $1.5M / Pre-Seed / Jan 01, 2021 | ||
| Inkblot is Canada’s top high-quality, secure and affordable video counselling service. They use proprietary matching algorithms to connect clients with the most effective mental health counsellors or life coaches based on their needs and preferences. Sessions can take place from the comfort of home or a quiet space at work..Life is filled withuncertainty, complexity, and ambiguity. Overwhelmed, people endure in silence: feeling empty, withdrawn, and unsettled without sufficient supports. | $512K / Seed / Apr 13, 2020 | ||
| See all 11 investments → | |||
Co-Investors
About Amplify Capital
Amplify Capital is the evolution of the MaRS Catalyst Fund, investing in mission-driven, double-bottom-line disruptors in health, education and clean tech. Every dollar invested in these companies generates a financial return and a social return. That’s how they amplify capital. And they further amplify their impact by encouraging partners, investors and co-investors to invest in companies where purpose drives profit. As investors, what they invest in today shapes the world of tomorrow.
Amplify Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Kathryn Wortsman
Managing Partner
|
|||
|
Louis Delorme
Principal
|
|||
Stacey Fruitman
Advisor - Amplify Capital (formerly MaRS Catalyst Fund)
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Kathryn Wortsman invest in?
Kathryn Wortsman invests primarily in Health Care, Artificial Intelligence and Sales startups, most often at Seed and Pre-Seed stage. Most of the 11 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Kathryn Wortsman?
Public channels for Kathryn Wortsman include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Kathryn Wortsman last invest?
The most recent investment recorded for Kathryn Wortsman closed in Jun 2025. Shizune tracks 11 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
